What sets Denmark apart is not just its policy direction but the openness of its regulatory culture. There’s a genuine willingness among stakeholders to engage in…
In Conversation
Our goal is to develop genome editing therapies that are both highly potent and fundamentally safe.
Denmark is not only a place to observe innovation. It’s a place where you can work with both public and private sectors – so come and…
We launched the world’s first dedicated neurodegeneration investment fund at a time when the field was seen as a graveyard for drug development. But I believed…
We believe the future is bright...Cannabis is growing at over 20 percent annually, and we are ready to grow with it.
In biotech, resilience is essential, and the ability to halt a programme early if it is not working is just as important as pushing forward when…
It is critical that Europe, and Switzerland in particular, continues to play a leadership role—not just in science, but in technology and AI-driven drug discovery as…
The sheer diversity and complexity of ATMPs necessitate that assessors maintain cutting-edge knowledge supported not only through training programmes, but also interdisciplinary collaboration across clinical, quality,…
Caring about our health prevents us from many diseases and supports a long and happy life.
Denmark must remain a country that values innovation, with a system ready to adopt the most effective, safest, and most patient-centred treatments available.
What began as a focused effort has become a multifaceted operation grounded in strong values and a collaborative spirit.
Success is deeply rooted in principles. At Principia, we don’t just deliver expertise—we lead with empathy, clarity, and commitment. That’s how we build trust, and that’s…
